• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

藤黄酸是一种新型的抗癌药物,能抑制细胞增殖、血管生成和转移。

Gambogic acid is a novel anti-cancer agent that inhibits cell proliferation, angiogenesis and metastasis.

机构信息

Department of Oral and Maxillofacial Surgery, College of Stomatology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Stomatology, Shanghai 200011, PR China.

出版信息

Anticancer Agents Med Chem. 2012 Oct 1;12(8):994-1000. doi: 10.2174/187152012802650066.

DOI:10.2174/187152012802650066
PMID:22339063
Abstract

Gambogic acid (GA) is a caged xanthone that is derived from Garcinia hanburyi and functions as a strong apoptotic inducer in many types of cancer cells. The distinct effectiveness of GA has led to its characterization as a novel anti-cancer agent. There is an increasing number of research studies focused on elucidating the molecular mechanisms of GA-induced anti-cancer effects, and several critical signaling pathways have been reported to be influenced by GA treatment. In this review, we summarize the multiple functional effects of GA administration in cancer cells including the induction of apoptosis, the inhibition of proliferation and the prevention of cancer metastasis and tumor angiogenesis.

摘要

藤黄酸(GA)是一种笼状的黄烷酮,来源于藤黄属植物,在多种癌细胞中具有很强的凋亡诱导作用。GA 的显著疗效使其成为一种新型抗癌药物。越来越多的研究集中在阐明 GA 诱导抗癌作用的分子机制,据报道,GA 处理会影响几个关键的信号通路。在这篇综述中,我们总结了 GA 在癌细胞中的多种功能作用,包括诱导细胞凋亡、抑制增殖以及预防癌症转移和肿瘤血管生成。

相似文献

1
Gambogic acid is a novel anti-cancer agent that inhibits cell proliferation, angiogenesis and metastasis.藤黄酸是一种新型的抗癌药物,能抑制细胞增殖、血管生成和转移。
Anticancer Agents Med Chem. 2012 Oct 1;12(8):994-1000. doi: 10.2174/187152012802650066.
2
Gambogic Acid as a Candidate for Cancer Therapy: A Review.藤黄酸作为癌症治疗的候选药物:综述。
Int J Nanomedicine. 2020 Dec 22;15:10385-10399. doi: 10.2147/IJN.S277645. eCollection 2020.
3
[Progress in research of the structural optimization of natural product-like Garcinia caged xanthones].[天然产物样藤黄属笼状呫吨酮结构优化的研究进展]
Yao Xue Xue Bao. 2014 Mar;49(3):293-302.
4
Therapeutic potential of gambogic acid, a caged xanthone, to target cancer.藤黄酸,一种笼状黄烷酮,具有靶向治疗癌症的潜力。
Cancer Lett. 2018 Mar 1;416:75-86. doi: 10.1016/j.canlet.2017.12.014. Epub 2017 Dec 13.
5
Absolute configuration of (-)-gambogic acid, an antitumor agent.(-)-藤黄酸,一种抗肿瘤试剂,其绝对构型。
J Nat Prod. 2011 Mar 25;74(3):460-3. doi: 10.1021/np100422z. Epub 2010 Nov 10.
6
Gambogic acid induces growth inhibition and differentiation via upregulation of p21waf1/cip1 expression in acute myeloid leukemia cells.藤黄酸通过上调急性髓性白血病细胞中p21waf1/cip1的表达诱导生长抑制和分化。
J Asian Nat Prod Res. 2014 Oct;16(10):1000-8. doi: 10.1080/10286020.2014.918108. Epub 2014 May 19.
7
Synthesis and evaluation of novel aza-caged Garcinia xanthones.新型氮杂笼状藤黄素的合成与评价。
Org Biomol Chem. 2012 Apr 28;10(16):3288-99. doi: 10.1039/c2ob07088j. Epub 2012 Mar 12.
8
Studies on chemical structure modification and structure-activity relationship of derivatives of gambogic acid at C(39).关于 C(39)位藤黄酸衍生物的化学结构修饰和构效关系的研究。
Chem Biodivers. 2012 Aug;9(8):1579-90. doi: 10.1002/cbdv.201100415.
9
Structure-activity relationship of Garcinia xanthones analogues: Potent Hsp90 inhibitors with cytotoxicity and antiangiogenesis activity.藤黄属氧杂蒽酮类似物的构效关系:具有细胞毒性和抗血管生成活性的强效热休克蛋白90抑制剂。
Bioorg Med Chem. 2016 Oct 1;24(19):4626-4635. doi: 10.1016/j.bmc.2016.07.067. Epub 2016 Aug 1.
10
Novel Natural Product-like Caged Xanthones Bearing a Carbamate Moiety Exhibit Antitumor Potency and Anti-Angiogenesis Activity In vivo.带有氨基甲酸酯部分的新型天然产物样笼状呫吨酮在体内表现出抗肿瘤效力和抗血管生成活性。
Sci Rep. 2016 Oct 21;6:35771. doi: 10.1038/srep35771.

引用本文的文献

1
Synthesis, characterization, and computational evaluation of some synthesized xanthone derivatives: focus on kinase target network and biomedical properties.某些合成的氧杂蒽衍生物的合成、表征及计算评估:聚焦激酶靶点网络和生物医学特性
Front Pharmacol. 2025 Jan 3;15:1511627. doi: 10.3389/fphar.2024.1511627. eCollection 2024.
2
Gambogic acid: Multi-gram scale isolation, stereochemical erosion toward epi-gambogic acid and biological profile.藤黄酸:多克级规模的分离、向表藤黄酸的立体化学转变及生物学特性
Front Nat Prod. 2022;1. doi: 10.3389/fntpr.2022.1018765.
3
Elevated level of neuroserpin is an indication for the resistance to gambogic acid-induced apoptosis and oxidative stress in triple-negative breast cancer cells.
神经丝氨酸蛋白酶水平升高表明三阴性乳腺癌细胞对藤黄酸诱导的细胞凋亡和氧化应激具有抗性。
Asian Biomed (Res Rev News). 2024 Apr 30;18(2):69-80. doi: 10.2478/abm-2024-0010. eCollection 2024 Apr.
4
Nano-Drug Delivery Systems Based on Natural Products.基于天然产物的纳米药物传递系统。
Int J Nanomedicine. 2024 Jan 18;19:541-569. doi: 10.2147/IJN.S443692. eCollection 2024.
5
Investigations into the antibacterial effects and potential mechanism of gambogic acid and neogambogic acid.藤黄酸和新藤黄酸的抗菌作用及潜在机制研究
Front Microbiol. 2022 Dec 12;13:1045291. doi: 10.3389/fmicb.2022.1045291. eCollection 2022.
6
Zinc Finger Proteins: Functions and Mechanisms in Colon Cancer.锌指蛋白:在结肠癌中的功能与机制
Cancers (Basel). 2022 Oct 26;14(21):5242. doi: 10.3390/cancers14215242.
7
Nuclear Targeted Peptide Combined With Gambogic Acid for Synergistic Treatment of Breast Cancer.核靶向肽联合藤黄酸协同治疗乳腺癌
Front Chem. 2022 Jan 28;9:821426. doi: 10.3389/fchem.2021.821426. eCollection 2021.
8
Gambogic amide inhibits angiogenesis by suppressing VEGF/VEGFR2 in endothelial cells in a TrkA-independent manner.藤黄酰胺通过非依赖于 TrkA 的方式抑制内皮细胞中的 VEGF/VEGFR2 抑制血管生成。
Pharm Biol. 2021 Dec;59(1):1566-1575. doi: 10.1080/13880209.2021.1998140.
9
Targeting Drug Chemo-Resistance in Cancer Using Natural Products.利用天然产物靶向治疗癌症的化疗耐药性。
Biomedicines. 2021 Sep 29;9(10):1353. doi: 10.3390/biomedicines9101353.
10
Novel Xanthone Derivatives Impair Growth and Invasiveness of Colon Cancer Cells In Vitro.新型黄烷酮衍生物抑制结肠癌体外生长和侵袭。
Biomolecules. 2021 Oct 7;11(10):1480. doi: 10.3390/biom11101480.